Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Ozempic’s Active Ingredient Shows Surprising Anti-Aging Effects

Ozempic can change your body. Can it change your life?

Ozempic and Wegovy may raise hair loss risk in some men

Scientists find Ozempic may slow aging itself

Ozempic and Wegovy linked to nearly 40% fewer asthma attacks

Ozempic and Wegovy may have an unexpected mental health benefit

The Rare Vision Side Effect of Ozempic and Wegovy You Should Know About

Ozempic does something unexpected to the brain’s hunger neurons

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic Could Fight Addiction Too – Scientists Finally Know How

Ozempic Changes Your Body, but Does It Change Your Life? A New Study Suggests Not

Scientists discover a ‘skinny gene’ mutation that acts like Ozempic

Hair Loss May Be an Overlooked Side Effect of Ozempic and Mounjaro

Ozempic and Mounjaro linked to a surprising hair loss risk

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging

The Ozempic and Wegovy mistake sending thousands to poison control

The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound

Ozempic changed obesity treatment, but experts say the real revolution is next

Ozempic and Wegovy linked to surprising drop in violent behavior

Most people who stop GLP-1 drugs like Ozempic eventually return

Quantum Worlds »